Health
International trial of blood thinners for COVID-19 treatment begins – News-Medical.Net
These trials, known as ACTIV-4 Antithrombotics, are part of the three planned adaptive trials in this area of clinical research, included in the Accelerating COVID-19 Therapeutic Interventions and Vaccines (ACTIV) initiative. They are expected to yield new da…
A recent news release by the National Institutes of Health (NIH) announces the start of two Phase 3 clinical trials to explore blood thinners as treatments for COVID-19.
These trials, known as ACTIV-4 Antithrombotics, are part of the three planned adaptive trials in this area of clinical research, included in the Accelerating COVID-19 Therapeutic Interventions and Vaccines (ACTIV) initiative. They are expected to yield new data on the safety and efficacy of these drugs in the treatment of activ…
-
Noosa News23 hours agoFranz Ferdinand: Australian Tour 2025
-
General17 hours agoDavid Littleproud’s own goal • Inside Story
-
Noosa News17 hours agoQueensland GP accused of rape, sexual assault and torture pleads for bail despite ‘disturbing’ allegations
-
Noosa News17 hours agoDesperate search for missing Queensland teen Phoebe Bishop pushes into remote bushland